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Breast cancer is the most common cancer among women in the
Western world, with a cumulative lifetime risk in Denmark of 1 in
12 (Danish National Board of Health, 1997). The number and
activity of natural killer cells have been reported as significantly
affected in depressed patients (Irwin et al, 1987; Maes et al, 1992;
Schleifer al, 1996; Andersen et al, 1998; Cohen et al, 1998), which
could be the possible mechanism for depression as a risk factor for
breast cancer.
At least two well-conducted case–control studies (Chen et al,
1995; Ginsberg et al, 1996) have demonstrated an association
between major negative life events and breast cancer, although
other large-scale follow-up studies have been negative (Jones et al,
1984; Ewertz, 1986; Kvikstad et al, 1994; Roberts et al, 1996;
Johansen and Olsen, 1997). Clinical affective and neurotic dis-
orders were not assessed in the studies of adverse life events.
The existence of a cancer-prone personality with depressive
and neurotic symptoms has been proposed mainly in case-
reports and studies with cross-sectional design; case–control
(Bleiker et al, 1996) or follow-up studies (Hagnell, 1966) have
been sparse.
In cohort studies of women with depressive symptoms
(Zonderman et al, 1989), neurotic disorders (Zilber et al, 1989)
and affective disorders (Weeke and Vaeth, 1986), the standardized
mortality ratio (SMR) of cancer in general was no different from
that in the normal population of women. In a cohort study, no
significant difference in breast cancer risk was reported among
women who rated themselves as depressive and those who did not
(Hahn and Petitti, 1988).
The aim of the present study was to test the hypothesis that
clinical affective or neurotic disorders are risk factors for breast
cancer. We also wanted to test if the co-variables: age at first
depressive or neurotic episode, duration of period from first
episode, type of diagnosis, calendar period at first episode, alcohol
abuse, or alcohol/drug non-specified abuse had effects as determi-
nants. In addition, we wanted to test whether a long psychiatric in-
patient treatment period, as a proxy variable for long periods of
supervised treatment with psychotropics, was a risk factor for
breast cancer development.
PATIENTS AND METHODS
The study population comprised women who had been admitted to
psychiatric departments in general hospitals or psychiatric hospitals
in Denmark with the first admission with a affective or a neurotic
disorder at an age of more than 15 during the period 1 April 1969
to 31 December 1993. Relevant information was drawn from
the Danish Psychiatric Central Register (Munk-Jørgensen and
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University Hospital, 23 Bispebjerg Bakke, DK 2400 Copenhagen, DenmarkMortensen, 1997), which since 1 April 1969 has been computerized
and updated to include all admissions to all psychiatric departments
and hospitals in the country. Each admission record includes the
personal identification number, date of admission, date of
discharge, one main discharge diagnosis and up to three auxiliary
discharge diagnoses. The personal identification number, which is
unique to every Danish citizen, incorporates sex and date of birth,
and permits accurate linkage of information between registries.
Discharge diagnoses were recorded according to the International
Classification of Diseases, 8th Revision (ICD-8) (WHO, 1967).
For the purpose of this study, the affective and neurotic diag-
noses were categorized in five types (Table 1). Types 1, 2 and 3
represented psychotic affective disorders, type 4 represented non-
psychotics and type 5 represented neurotic disorders. Cohort entry
was defined as the date of first admission with an affective or
neurotic disorder, and the patient was categorized according to the
type of diagnosis presented during this admission. If re-admitted to
a psychiatric department with a diagnosis belonging to another
type with a lower number, the patient was re-categorized from that
date and onwards with the new lower number; however, if re-
admitted with the same type of diagnosis or another type with a
higher number, the patient’s categorization remained unchanged.
Diagnostic information of alcohol abuse (ICD-8 code 303) and
diagnostic information of alcohol/drug non-specified abuse (code
304) was retained together with first date of diagnosis. If re-
admitted with a diagnosis of schizophrenia (code 295), the patient
was censored from the first date of admission with this diagnosis.
The study population was linked to the files of the Danish
Cancer Registry, which collects information about all patients with
cancer in Denmark (Storm et al, 1996). The period of follow-up
for cancer occurrence was taken from the date of first admission
with an affective or neurotic disorder (cohort entry) until the date
of death (obtained from the national mortality files), date of diag-
nosis of schizophrenia, or 31 December 1993, whichever occurred
first. Of the 67 285 women 15 years or older, diagnosed with an
affective or neurotic disorder, 637 (0.1%) had been diagnosed with
breast cancer and entered onto the Cancer Registry before date of
cohort entry. They were excluded from this study, leaving 66 648
women for evaluation (Table 2).
Statistical analysis
The expected numbers of cancers were calculated by multiplying the
number of person-years of cohort members by the breast cancer inci-
dence for Danish women in 5-year age groups and calendar periods
of observation. Tests of significance and confidence intervals for the
standardized incidence ratio (SIR), taken as the ratio of observed to
expected breast cancers, were based on standard log-linear models,
multiplicative intensity models, often termed ‘Poisson regression’
(Clayton and Hills, 1993).
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Table 1 Five ordinal types of affective and neurotic diagnoses
Types Diagnosesa Codes
1. Bipolar Manic-depressive psychosis, manic type 296.19
Manic-depressive psychosis, circular type 296.39
2. Unipolar Involutional melancholia 296.09
Manic-depressive psychosis, depressed type 296.29
Manic-depressive psychosis, other 296.89
Manic-depressive psychosis, unspecified 296.99
3. Reactive Reactive depressive psychosis 298.09
4. Dysthymic Affective (cyclothymic) personality disorder 301.19
Neurotic depression 300.49
5. Neurotic All other neuroses 300.00–300.99 (except 300.49)
Other personality disorders 301.81
a Modified Danish revision of the eighth revision of the International Classification of Diseases.
Table 2 Descriptive characteristics of 66 648 women with affective or
neurotic disorders
Characteristic Number Per cent
Entire study cohort 66 648 100
Age at cohort entry
< 30 13 105 19.7
30–39 14 488 21.7
40–49 13 155 19.7
50–59 11 254 16.9
60–69 8 170 12.2
70–79 5 084 7.7
> 80 1 392 2.1
Year of cohort entry
1969–1973 15 305 23.0
1974–1978 17 323 26.0
1979–1983 13 840 20.0
1984–1988 11 136 17.4
1989–1993 9 044 13.6
Initial type of diagnosis
Affective
Bipolar 2 417 3.6
Unipolar 16 289 24.4
Reactive 10 222 15.3
Dysthymic 9 608 14.4
Neurotic 28 112 42.2
Place of residence at cohort entry
Capital 11 930 17.9
Suburbs 8 958 13.4
Provincial towns 26 794 40.2
Rural areas 18 961 28.5
Missing information 5
Total number of admissions
1 28 418 42.6
2–5 28 556 42.8
6–10 6 379 9.6
³ 11 3 295 4.9
Diagnosis of abuse
Yes
Alcohol 5 355 8.0
Alcohol/drug 8 258 12.4
No 53 035 87.6RESULTS
For the 66 648 cohort members, 775 522 person-years of follow-
up were accrued, median follow-up was 11.6 years (range 0–25
years) and median age at first admission 44 years (Table 2). The
cohort experienced a total of 199 910 psychiatric admissions, of
which 32 474 entailed a re-categorization of type of diagnosis
compared to that of previous admissions.
At cohort entry, a total of 38 536 patients (58%) were registered
with an affective disorder and 28 112 (42%) with a neurotic
disorder. During follow-up, 28 418 patients (42%) were admitted
only once. Psychiatric co-morbidity with alcohol abuse or alcohol/
drug abuse was registered in 5355 (8%) and 8258 (12%) of the
subjects respectively. Follow-up was suspended because of a diag-
nosis of schizophrenia in 1240 patients (2%) and because of death
in 16 435 patients (25%).
Overall, 1270 breast cancers were observed, and 1241 were
expected, yielding a SIR of 1.02 (95% confidence interval (CI)
0.97–1.08) (Table 3). The diagnoses of primary invasive breast
cancer were confirmed histopathologically in 97.5% of cases.
Neither age nor year at cohort entry showed any remarkable
pattern or significant findings in any of the subgroup analyses
(Table 3). The cumulative risk of women with affective and
neurotic disorder for breast cancer, by time from date of first
admission, was similar to the expected cumulative risk, which was
based on the national incidence rate of female breast cancer
(Figure 1). Type of diagnosis showed no statistical significant
difference, although the risk was slightly higher in the subgroup of
women with dysthymia (SIR of 1.10) (95% CI 0.95–1.25). Women
with a diagnosis of alcohol abuse had an increased risk (SIR of
1.12) (95% CI 0.94–1.30), but the difference was not significant.
There is no evidence of a positive relationship between length of
admission and breast cancer risk.
DISCUSSION
We found no support for the hypothesis of an increased risk of
breast cancer among women discharged from psychiatric depart-
ments or hospitals with affective or neurotic disorders, and none of
the co-variables – age at cohort entry, calendar year at cohort entry,
type of diagnosis, number of admissions, length of admissions,
period of follow-up, alcohol abuse or alcohol/drug abuse – had any
appreciable effect as determinants. The large data set implied the
narrow confidence intervals, which exclude the possibility that this
result is a coincidence.
Large well-performed cohort studies of affective or neurotic
disorders as risk factors for breast cancer are sparse. In a cohort
Breast cancer after depression 909
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Table 3 Observed number (Obs) and standardised incidence ratio (SIR) for
breast cancer in 66 648 women with affective or neurotic disorders by type of
diagnosis, use of treatment as in-patients in psychiatric departments,
personal characteristics and diagnoses of abuse
Characteristic Number of Obs. SIR 95% Cl
person-years
Entire study cohort 775 522 1 270 1.02 0.97–1.08
Age at cohort entry
< 30 65 052 2 0.72 0.12–2.22
30–39 149 319 57 0.91 0.69–1.17
40–49 178 385 271 1.01 0.90–1.14
50–59 156 796 318 0.99 0.88–1.10
60–69 125 997 315 1.06 0.95–1.18
70–79 75 281 220 1.04 0.91–1.19
³ 80 24 692 87 1.10 0.88–1.34
Year at cohort entry
1969–1973 31 753 33 1.06 0.74–1.47
1974–1978 112 124 127 0.95 0.79–1.12
1979–1983 177 593 254 1.02 0.90–1.15
1984–1988 217 482 362 1.00 0.90–1.11
1989–1993 236 569 494 1.06 0.97–1.16
Type of diagnosis
Bipolar 38 709 56 0.90 0.69–1.16
Unipolar 190 264 377 0.99 0.90–1.10
Reactive 115 551 193 1.02 0.88–1.17
Dysthymic 130 012 228 1.10 0.95–1.25
Neurotic 300 986 416 1.03 0.94–1.14
Number of admissions
1 392 939 632 1.02 0.94–1.10
2 159 544 270 1.04 0.93–1.17
3 78 411 143 1.11 0.94–1.31
4–5 70 959 116 0.99 0.82–1.18
6–10 52 860 79 0.91 0.72–1.12
³ 11 20 809 30 0.93 0.64–1.31
Length of admissions
< 1 year 737 568 1 215 1.03 0.98–1.09
1–2 years 26 152 40 0.91 0.66–1.22
> 2 years 11 801 15 0.69 0.40–1.10
Period at follow-up (years)
0–4 291 547 383 1.00 0.91–1.11
5–9 223 626 345 0.99 0.89–1.10
10–19 239 089 492 1.06 0.97–1.16
³ 20 21 260 50 1.01 0.76–1.32
Diagnosis of abuse
Alcohol 85 758 140 1.12 0.94–1.30
Alcohol/drug 130 420 206 1.04 0.91–1.19
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Figure 1 Observed and expected risk of primary invasive breast cancer by
time from first psychiatric admission with affective or neurotic disorderstudy of women, self-rated with Minnesota Multiphasic
Personality Inventory, 9% were depressive at baseline. During 10
years of follow-up 117 women developed breast cancer, and no
significant difference was reported among women who rated
themselves as depressive and those who did not (Hahn and Petitti,
1988). This study was hampered by a highly selected study popu-
lation and most women were under age of 50 years. In a Danish
cohort study of 1325 women discharged from psychiatric depart-
ments and hospitals with bipolar or unipolar manic-depressive
disorders the standardized mortality ratio of cancer in general was
not different from the rate in the general population, but the
specific standardized mortality ratio of breast cancer was not
assessed (Weeke and Vaeth, 1986). The present study represents
the first large cohort study of affective and neurotic disorders in
relation to breast cancer.
Our data from the nationwide registries have high validity
(Storm, 1977; Kessing, 1998) and the same diagnostic classifica-
tion system has been used during the whole study period (WHO,
1967). The information about cancer cases in Denmark is almost
complete (Storm, 1988; Rostgaard and Lynge, 1997), and we have
no reason to believe that this cohort had a higher emigration rate
than that of the general population of females, i.e. 0.5% per year
(Statistics Denmark, 1998). In addition, we supposed that the
median follow-up period of 11.6 years was sufficient for aetio-
logical cancer research.
Being a register-study all data have been originally collected for
other purposes, and thus the available data do not cover risk
factors for breast cancer, other than age and calendar period, which
were included in all analyses. There is no evidence that distribu-
tion of well-established risk factors for breast cancer among
Danish women admitted to psychiatric departments with affective
or neurotic disorders are different from the general population of
women, except for reduced fertility rate (Ødegaard, 1980), which
could have implied a slight overestimation. Our cohort did not
comprise all Danish women with depressive or neurotic disorder:
patients with non-recognized affective or neurotic disorders and
patients treated only as out-patients or in general practice were not
included.
The proportion of women with neurotic disorders or non-
psychotic affective disorders was substantially reduced during the
study period because the number of available beds in psychiatric
departments and hospitals was reduced by more than 50%. Since no
differences in breast cancer risk were observed during the study
period by calendar year at cohort entry, we have no reason to believe
that cases with neurotic disorders or non-psychotic affective dis-
orders have more risk than cases with psychotic affective disorders.
We suppose that the low frequency of alcohol abuse (8%) was
due to the well-known tendency to underreport this stigmatizing
diagnosis in women during the actual study period. Non-differen-
tial misclassification could, therefore, be the reason that alcohol
abuse was not a significant risk factor in this cohort, in contrast
to studies of females with alcohol abuse (Smith-Warner, 1998).
Similarly, unspecified alcohol/drug abuse was not a risk factor
in this cohort. We found no evidence of a positive relationship
between length of admission and breast cancer risk, and indeed the
trend with increased admission-length was negative.
Women admitted with psychiatric disorders have a higher
prevalence of chronic medical illness (Fink, 1992) compared to the
general population of women, implying a higher use of the health
care system and increased possibility of having breast cancer diag-
nosed, which could have induced a slight overestimation. In this
Danish nationwide cohort study with good clinical case identifica-
tion, large sample size and low loss of follow-up, women
discharged from psychiatric departments and hospitals with affec-
tive or neurotic disorders have the same incidence of breast cancer
as women in the general population, adjusted for age and calendar
period.
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